Drugs & Targets FDA Approves Chelator Jadenu, an Oral Formulation of Exjade April 03, 2015Vol.41 No.13
Drugs & Targets FDA updates label for Zytiga plus prednisone in metastatic castration-resistant prostate cancer April 03, 2015Vol.41 No.13
Drugs & Targets FDA Grants Accelerated Approval to Farydak For Patients with Multiple Myeloma March 31, 2015Vol.38 No.03
Drugs & Targets Rich Pharmaceuticals plans to launch clinical trials at Khon Kaen University in Thailand March 27, 2015Vol.41 No.12
Drugs & Targets Teikoku Pharma USA submits NDA for alcohol-free docetaxel formulation March 27, 2015Vol.41 No.12
